• Tobramycin, Trough, Serum
  • Lysosomal Acid Lipase, Gene Variation
  • Breast tumor
  • Prostatic Acid Phosphatase (PAP)
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • Nicotine replacement therapy
  • 17-Hydroxyprogesterone, Amniotic fluid
  • Occult Blood, Fecal
  • Inherited Insulin Resistance Syndromes (INSR) Genetic Testing
  • Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Nervous System/Brain Cancer Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Nervous System/Brain Cancer Panel, NGS
Medical Test

Turnaround Time
Access to Nervous System/Brain Cancer Panel, NGS is restricted.